Search results
Emergent BioSolutions sells Baltimore facility to Bora Pharmaceuticals By Investing.com
Investing.com· 23 hours agoEmergent BioSolutions Inc. (NYSE: EBS), a biopharmaceutical company, has struck a deal to divest its...
Pharma giant Eli Lilly suing providers of fake meds passed off as Mounjaro, Zepbound
The Washington Times· 14 hours agoPharmaceutical company Eli Lilly is taking legal action against wellness centers, medical spas and other parties passing off fake medicine as Lilly products Mounjaro and Zepbound ...
Eli Lilly Files More Lawsuits at Sellers of Counterfeit Mounjaro, Zepbound
The Wall Street Journal· 19 hours agoThe pharmaceutical company said it filed legal actions against med-spas, wellness centers and other...
Vertex reaches pricing deal with NHS for cystic fibrosis drugs - The Boston Globe
The Boston Globe· 12 hours agoVertex Pharmaceuticals has reached a pricing deal for its cystic fibrosis drugs with the National...
Jazz Pharmaceuticals' tremor drug fails in mid-stage study
Reuters via Yahoo News· 22 hours ago(Reuters) -Jazz Pharmaceuticals said on Thursday its experimental drug to treat a common movement disorder failed to reduce tremor severity in a mid-stage study, sending the ...
Vertex Pharmaceuticals (NASDAQ:VRTX): The Best Healthcare Stock to Buy in 2024?
Insider Monkey via Yahoo Finance· 2 days agoSince Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) ranks 7th on the list, it deserves a deeper...
Celadon Pharmaceuticals (LON:CEL) Shares Down 8.3%
ETF DAILY NEWS· 1 day agoCeladon Pharmaceuticals Plc (LON:CEL – Get Free Report)’s stock price was down 8.3% during mid-day trading on Thursday . The company traded as low as GBX 65 ($0.83) and last ...
Mirum Pharmaceuticals (MIRM) Soars 27.3%: Is Further Upside Left in the Stock?
Zacks via Yahoo Finance· 3 days agoMirum Pharmaceuticals (MIRM) saw its shares surge in the last session with trading volume being...
Investors might be losing patience for Apellis Pharmaceuticals' (NASDAQ:APLS) increasing losses, as...
Simply Wall St. via Yahoo Finance· 2 days agoWhile Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) shareholders are probably generally happy, the...
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) CEO Sells $1,470,833.89 in Stock
ETF DAILY NEWS· 2 days agoCorbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP – Get Free Report) CEO Yuval Cohen sold 29,317 shares of the business’s stock in a transaction that occurred on Friday, ...